Kaposi's sarcoma herpes virus (KSHV) impairs antigen presentation in latently infected cells.

被引：0
|
作者：
Brander, C
Suscovich, T
Lee, Y
O'Connor, PG
Walker, BD
Scadden, DT
机构：
[1] Massachusetts Gen Hosp, AIDS Res Ctr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
来源：
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2000年 / 23卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
41
引用
收藏
页码：A25 / A25
页数：1
相关论文
共 50 条
  • [31] Regulation of emmprin in Kaposi's sarcoma-associated herpesvirus (KSHV)-infected cells: a novel strategy developed against KSHV-related diseases
    Qin, Zhiqiang
    Dai, Lu
    Bratoeva, Momka
    Toole, Bryan
    Parsons, Chris
    CANCER RESEARCH, 2011, 71
  • [32] Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide
    Davis, David A.
    Mishra, Suraj
    Anagho, Holda A.
    Aisabor, Ashley I.
    Shrestha, Prabha
    Wang, Victoria
    Takamatsu, Yuki
    Maeda, Kenji
    Mitsuya, Hiroaki
    Zeldis, Jerome B.
    Yarchoan, Robert
    ONCOTARGET, 2017, 8 (31) : 50342 - 50358
  • [33] Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters
    Okroj, Marcin
    Tedeschi, Rosamaria
    Mancuso, Roberta
    Brambilla, Lucia
    Tourlaki, Athanasia
    Dillner, Joakim
    Blom, Anna M.
    VACCINE, 2011, 29 (06) : 1129 - 1134
  • [34] Reservoir cells of Kaposi's sarcoma-associated herpesvirus (KSHV) in peripheral blood mononuclear cells (PBMC) during Kaposi's sarcoma (KS)
    Pellet, C
    Hamel, Y
    Calvo, MC
    Morel, P
    Calvo, F
    Lebbé, C
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (06) : 1092 - 1092
  • [35] Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters
    Okroj, M.
    Tedeschi, R.
    Mancuso, R.
    Brambilla, L.
    Tourlaki, A.
    Dillner, J.
    Blom, A.
    MOLECULAR IMMUNOLOGY, 2011, 48 (14) : 1716 - 1716
  • [36] Persistence of Kaposi sarcoma associated herpesvirus (KSHV) infected cells in KSHV/HIV-1 coinfected subjects without KSHV-associated diseases
    Campbell, TB
    Staskus, KA
    Folkvord, J
    White, IE
    Neid, J
    Zhang, XQ
    Connick, E
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (03): : 367 - 371
  • [37] Targeting the Kaposi’s sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells
    Coral Orel Haddad
    Inna Kalt
    Yehuda Shovman
    Lei Xia
    Yehuda Schlesinger
    Ronit Sarid
    Oren Parnas
    Virology Journal, 18
  • [38] Targeting the Kaposi's sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells
    Haddad, Coral Orel
    Kalt, Inna
    Shovman, Yehuda
    Xia, Lei
    Schlesinger, Yehuda
    Sarid, Ronit
    Parnas, Oren
    VIROLOGY JOURNAL, 2021, 18 (01)
  • [39] Association of Kaposi's sarcoma associated herpesvirus (KSHV) DNA in bronchoalveolar lavage fluid of HIV infected individuals with bronchoscopically diagnosed tracheobronchial Kaposi's sarcoma
    Howard, MR
    Brink, NS
    Whitby, D
    Tedder, RS
    Miller, RF
    SEXUALLY TRANSMITTED INFECTIONS, 1998, 74 (01) : 27 - 31
  • [40] Lymphatic reprogramming of blood vascular endothelial cells by Kaposi's sarcoma-associated herpes virus
    Hong, Y
    Foreman, K
    Shin, J
    Hirakawa, S
    Curry, CL
    Sage, DR
    Liberman, T
    Dezube, BJ
    Fingeroth, JD
    Detmar, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A132 - A132
12345